A higher degree of criticism about the effectiveness of bosentan for digital ulcers in scleroderma patients, as for interstitial disease, is also necessary: comment on the article by Seibold et al. (Q42992767)
Jump to navigation
Jump to search
scientific article published in October 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A higher degree of criticism about the effectiveness of bosentan for digital ulcers in scleroderma patients, as for interstitial disease, is also necessary: comment on the article by Seibold et al. |
scientific article published in October 2010 |
Statements
1 reference
A higher degree of criticism about the effectiveness of bosentan for digital ulcers in scleroderma patients, as for interstitial disease, is also necessary: comment on the article by Seibold et al. (English)
1 reference
1 October 2010
1 reference
1 reference
62
1 reference
10
1 reference
3128-9; author reply 3129-30
1 reference
Identifiers
1 reference
1 reference